[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370367-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370367-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","genome-wide-crispr-screen-identifies-irf1-and-tfap4-as-transcriptional-regulators-of-galectin-9-in-t-cell-acute-lymphoblastic-leukemia-cancer","Genome-wide CRISPR screen identifies IRF1 and TFAP4 as transcriptional regulators of Galectin-9 in T cell acute lymphoblastic leukemia - Cancer","","Genome-wide CRISPR screening using intracellular Galectin-9 staining defined the transcriptional regulators and epigenetic circuitry controlling Galectin-9 in pediatric T cell acute lymphoblastic leukemia (T-ALL). The study found that IRF1 is indispensable for Galectin-9 expression at its promoter, while TFAP4 binds an enhancer in T-ALL cells with higher Galectin-9 levels to fine-tune expression. The results link elevated Galectin-9 to poorer overall survival and support a flow-based CRISPR approach to dissect transcriptional regulation in cancer.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/genome-wide-crispr-screen-identifies-irf1-and-tfap4-as-transcriptional-regulators-of-galectin-9-in-t-cell-acute-lymphoblastic-leukemia-cancer/370367/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/genome-wide-crispr-screen-identifies-irf1-and-tfap4-as-transcriptional-regulators-of-galectin-9-in-t-cell-acute-lymphoblastic-leukemia-cancer/370367.png","ImageObject",300,407,{"name":42,"@type":43},"Riley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-15","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the goal of the genome-wide CRISPR screen in this study?","Question",{"text":63,"@type":64},"To identify positive regulators of Galectin-9 expression in pediatric T-ALL based on intracellular Galectin-9 staining.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which transcription factors were found to regulate Galectin-9, and how?",{"text":68,"@type":64},"IRF1 was observed on the promoter and is responsible and indispensable for Galectin-9 expression, while TFAP4 binds an enhancer in T-ALL cells associated with higher Galectin-9 levels.",{"name":70,"@type":61,"acceptedAnswer":71},"How is Galectin-9 expression related to patient outcomes in pediatric T-ALL?",{"text":72,"@type":64},"Higher Galectin-9 (LGALS9) expression was associated with lower overall survival, even though LGALS9 was expressed across patients with variable levels.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370367,1790782020,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","CANCER  \nGenome-wide CRISPR screen identifies IRF1 and TFAP4 as transcriptional regulators of Galectin-9 inT cell acute lymphoblastic leukemia  \nCaroline R. M. Wiggers1,2†, BurakYüzügüldü1,2†, Nathanial G. Tadros3, Tayla B. Heavican-Foral1,2, Eugene Y. Cho1, Zachary C. Eisenbies1, Merve Ozdemir1, Steffen B. Kulp3, Yun-Cheol Chae4, Alejandro Gutierrez4, Jens G. Lohr2,3,5,6*‡, Birgit Knoechel1,2,5,6,7*‡  \nGalectin-9 is overexpressed in a variety of cancers and associated with worse clinical outcome in some cancers. However, the regulators driving Galectin-9 expression are unknown. Here, we defined the transcriptional regulators and epigenetic circuitry of Galectin-9 in pediatric T cell acute lymphoblastic leukemia (T-ALL), as an example of a disease with strong Galectin-9 expression, in which higher expression was associated with lower overall survival. By performing a genome-wide CRISPR screen, we identified the transcription factors IRF1 and TFAP4 as key regulators for Galectin-9 expression by binding its regulatory elements. Whereas IRF1 was observed exclusively on the promoter, TFAP4 binding was detected at an enhancer solely inT-ALL cells associated with higher Galectin- 9 levels. Together, our results show that IRF1 is responsible and indispensable for Galectin-9 expression and TFAP4 further fine-tunes its expression. Our approach, a flow-based genome-wide CRISPR screen complemented by transcription factor binding and enhancer mapping, creates innovative opportunities for understanding and manipulating epigenetic transcriptional regulation in cancer.  \ncopyright © 2025 the Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. no claim to original U.S.  \nGovernment Works. distributed under a creative commons Attribution noncommercial license 4.0 (cc BY-nc) .  \nINTRODUCTION  \nGalectin-9, encoded by the LGALS9 gene, is a member of the galectin family with carbohydrate-binding domains for β-galactosidases that bind to cell surface and extracellular matrix glycans ( 1–3) . It has been shown to play a role in a variety of biological processes, including immune responses and tumor progression (3, 4) . Although, in some solid tumors, Galectin-9 is associated with an antitumor role by inducing tumor cell apoptosis, it is found to be overexpressed in a variety of cancers and is associated with worse overall survival in some solid and hematologic cancers including pancreatic carcinoma and acute myeloid leukemia (AML) (4–6) . Galectin-9 has been described as an important regulator ofthe immunosuppressive tumor microenvironment and therefore seen as a promising immunotherapeutic target (4, 5). It is secreted by various immune cell types and binds to multiple receptors including Tim-3, VISTA, and PD-1 (3, 5, 7–10). Binding to Tim-3 on T cells has been described to induce T cell death in CD4+ and CD8+ T cells, whereas PD-1 attenuates this process (5). In addition, it has been reported that AML cells secrete Galectin-9 and that its binding to VISTA and Tim-3 induce granzyme B–mediated self-killing in cytotoxic T cells ( 10). In early T cell progenitor acute lymphoblastic leukemia (ETPALL), we have previously described a role for Galectin-9 expressed by leukemia cells in mediating CD8+ T cell dysfunction through Tim-3 binding (11) .  \n1department of Pediatric Oncology, dana-Farber cancer institute, Boston, MA, USA. 2harvard Medical School, Boston, MA, USA. 3department of Medical Oncology, dana-Farber cancer institute, Boston, MA, USA. 4department of Oncology, St. Jude children’s Research hospital, Memphis, tn, USA. 5Broad institute of Mit and harvard, cambridge, MA, USA. 6huntsman cancer institute, University of Utah, Salt lake city, Ut, USA. 7department of hematology/Oncology, Boston children’s hospital, Boston, MA, USA.  \n*corresponding [author. email:](author. email:) [birgit.knoechel@hci.utah.edu](birgit.knoechel@hci.utah.edu) (B.K.); jens.lohr@hci. [utah.edu](utah.edu) (J.G. l.)  \n†thes","cbCaicObQfBCwwOs","https://ap.wps.com/l/cbCaicObQfBCwwOs","pdf",3013318,15,"English","# Introduction\n## Galectin-9 roles and receptors\n## Rationale for mapping transcriptional regulation\n# Study overview and findings\n## Identifying IRF1 and TFAP4 as regulators\n## Promoter versus enhancer binding\n## Implications for epigenetic transcriptional regulation","[{\"question\":\"What was the goal of the genome-wide CRISPR screen in this study?\",\"answer\":\"To identify positive regulators of Galectin-9 expression in pediatric T-ALL based on intracellular Galectin-9 staining.\"},{\"question\":\"Which transcription factors were found to regulate Galectin-9, and how?\",\"answer\":\"IRF1 was observed on the promoter and is responsible and indispensable for Galectin-9 expression, while TFAP4 binds an enhancer in T-ALL cells associated with higher Galectin-9 levels.\"},{\"question\":\"How is Galectin-9 expression related to patient outcomes in pediatric T-ALL?\",\"answer\":\"Higher Galectin-9 (LGALS9) expression was associated with lower overall survival, even though LGALS9 was expressed across patients with variable levels.\"}]","Genome-wide CRISPR screen identifies IRF1 and TFAP4 as transcriptional regulators of Galectin-9 in T cell acute lymphoblastic leukemia - Cancer | PDF",1790188195,38,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/21b3137a97797663f5af11320e51f1ef.webp",983,1250,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a24efdb8767df019aa81474880da80f1.webp",982,1249,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/074a4dc3920e152c1dadcffdaefc039b.webp",981,1248,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a57a32c9ec84a09e05efe8a6c286456d.webp",980,1247]